E-Posters - ACUTE ISCHEMIC STROKE MANAGEMENT 01.00 - ACUTE ISCHEMIC STROKE MANAGEMENT - 01.05 - NEUROINTERVENTION P2079 - ESOC25-1511 TIROFIBAN BEYOND STENTING: A NEW HORIZON IN MECHANICAL THROMBECTOMY Pablo Abizanda Saro 1 , Luca Lpez Trashorras 1 , Lorena Franco Rubio 1 , Ana Aldaz Burgoa 1 , Nicols Rodrguez Albacete 1 , Patricia Simal Hernndez 1 , Jos Antonio Egido Herrero 1 , Manuel Moreu 2 , Carlos Prez-Garca 2 , Santiago Rosati 2 , Alfonso Lpez-Fras Lpez-Jurado 2 , Carmen Trejo 2 , ngela Huete Schmolling 2 , Carlos Gmez-Escalonilla 1 1 Neurology, Hospital Clnico San Carlos, Madrid, Spain, 2 Neuroradiology, Hospital Clnico San Carlos, Madrid, Spain Background and Aims: Tirofiban is increasingly utilized in endovascular procedures, particularly for large intracranial vessel occlusions requiring stent placement
Produced primarily in the liver, glutathione acts as a key player in various metabolic processes, helping to neutralize free radicals and toxins that can damage cells
Month 1: Initial stabilization, possible subtle improvements
Research professionals often prioritize peptide products that provide dependable vial presentation systems, organized scientific labeling structures, and laboratory-grade compatibility suitable for advanced scientific operations
As with other IV-based treatments, this involves setting up an intravenous injection and delivering glutathione directly into the bloodstream
This study also suggests a potential role for GSH as an adjuvant therapeutic target for normalizing 25(OH)VD 3 status in vulnerable populations
